Form 4: Doximity Director Phoebe Yang Watkin Sells Shares Under 10b5-1 Plan

Phoebe Yang Watkin, a director at Doximity, Inc., sold 1,940 shares of Class A Common Stock at a price of $28.22 per share on July 29, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• On July 29, 2024, Phoebe Yang Watkin, a director of Doximity, Inc. (DOCS), sold 1,940 shares of Class A Common Stock.
• The sale was executed at a price of $28.22 per share.
• Following the transaction, Watkin directly owns 12,269 shares of Doximity's Class A Common Stock.
• The sale was conducted under a Rule 10b5-1 trading plan adopted on August 30, 2023.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing for an insider sale. The sale was conducted under a pre-arranged 10b5-1 trading plan, so it doesn't necessarily reflect a negative sentiment towards the company. Therefore, the sentiment is neutral.

Industry Context

Insider sales are a common occurrence, and sales under 10b5-1 plans are often viewed as less impactful since they are pre-scheduled. However, investors often monitor insider transactions for signals about a company's prospects.

Stakeholder Impact

• The sale of shares by a director could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.

Key Dates